254 related articles for article (PubMed ID: 24180631)
1. S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3.
Kan J; Guo W; Huang C; Bao G; Zhu Y; Zhu YZ
Antioxid Redox Signal; 2014 May; 20(15):2303-16. PubMed ID: 24180631
[TBL] [Abstract][Full Text] [Related]
2. ZYZ-803, a novel hydrogen sulfide-nitric oxide conjugated donor, promotes angiogenesis via cross-talk between STAT3 and CaMKII.
Xiong Y; Chang LL; Tran B; Dai T; Zhong R; Mao YC; Zhu YZ
Acta Pharmacol Sin; 2020 Feb; 41(2):218-228. PubMed ID: 31316179
[TBL] [Abstract][Full Text] [Related]
3. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.
Wu J; Guo W; Lin SZ; Wang ZJ; Kan JT; Chen SY; Zhu YZ
Cell Death Dis; 2016 Aug; 7(8):e2339. PubMed ID: 27537522
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms.
Huang C; Kan J; Liu X; Ma F; Tran BH; Zou Y; Wang S; Zhu YZ
PLoS One; 2013; 8(7):e69205. PubMed ID: 23874913
[TBL] [Abstract][Full Text] [Related]
5. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways.
Du G; Zhu H; Yu P; Wang H; He J; Ye L; Fu F; Zhang J; Tian J
Eur J Pharmacol; 2013 Jan; 700(1-3):173-80. PubMed ID: 23276662
[TBL] [Abstract][Full Text] [Related]
6. The Pharmacological Effects of S-Propargyl-Cysteine, a Novel Endogenous H2S-Producing Compound.
Wen YD; Zhu YZ
Handb Exp Pharmacol; 2015; 230():325-36. PubMed ID: 26162842
[TBL] [Abstract][Full Text] [Related]
7. Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats' stroke model.
Dong W; Xian Y; Yuan W; Huifeng Z; Tao W; Zhiqiang L; Shan F; Ya F; Hongli W; Jinghuan W; Lei Q; Li Z; Hongyi Q
J Ethnopharmacol; 2016 Sep; 191():169-179. PubMed ID: 27301615
[TBL] [Abstract][Full Text] [Related]
8. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
9. S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway.
Wang M; Tang W; Xin H; Zhu YZ
PLoS One; 2016; 11(9):e0163289. PubMed ID: 27649298
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury.
Cao X; Li B; Han X; Zhang X; Dang M; Wang H; Du F; Zeng X; Guo C
Apoptosis; 2020 Jun; 25(5-6):341-353. PubMed ID: 32333220
[TBL] [Abstract][Full Text] [Related]
11. KPNA2 promotes angiogenesis by regulating STAT3 phosphorylation.
Jia Y; Wang Q; Liang M; Huang K
J Transl Med; 2022 Dec; 20(1):627. PubMed ID: 36578083
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway.
Zhou Y; Li XH; Zhang CC; Wang MJ; Xue WL; Wu DD; Ma FF; Li WW; Tao BB; Zhu YC
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C305-17. PubMed ID: 26879375
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
14. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
15. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway.
Wang Q; Liu HR; Mu Q; Rose P; Zhu YZ
J Cardiovasc Pharmacol; 2009 Aug; 54(2):139-46. PubMed ID: 19546814
[TBL] [Abstract][Full Text] [Related]
16. C-C Motif Chemokine 8 promotes angiogenesis in vascular endothelial cells.
Xue S; Tang H; Zhao G; Shen Y; Yang EY; Fu W; Shi Z; Tang X; Guo D
Vascular; 2021 Jun; 29(3):429-441. PubMed ID: 32972333
[TBL] [Abstract][Full Text] [Related]
17. Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2.
Parma L; Peters HAB; Johansson ME; Gutiérrez S; Meijerink H; de Kimpe S; de Vries MR; Quax PHA
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629855
[TBL] [Abstract][Full Text] [Related]
18. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
[TBL] [Abstract][Full Text] [Related]
19. S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway.
Wu WJ; Jia WW; Liu XH; Pan LL; Zhang QY; Yang D; Shen XY; Liu L; Zhu YZ
Redox Biol; 2016 Dec; 10():157-167. PubMed ID: 27744121
[TBL] [Abstract][Full Text] [Related]
20. Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis.
Cochrane A; Kelaini S; Tsifaki M; Bojdo J; Vilà-González M; Drehmer D; Caines R; Magee C; Eleftheriadou M; Hu Y; Grieve D; Stitt AW; Zeng L; Xu Q; Margariti A
Stem Cells; 2017 Apr; 35(4):952-966. PubMed ID: 28207177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
